Crystal Structure of an Hsp90–Geldanamycin Complex: Targeting of a Protein Chaperone by an Antitumor Agent
C. Erec Stebbins, Alicia A. Russo, Christine B. Schneider et al. · Cell · 1997
The Hsp90 chaperone is required for the activation of several families of eukaryotic protein kinases and nuclear hormone receptors, many of which are protooncogenic and play a prominent role in cancer. The geldanamycin antibiotic has antiproliferative and antitumor effects, as it binds to Hsp90, inhibits the Hsp90-mediated conformational maturation/refolding reaction, and results in the degradation of Hsp90 substrates. The structure of the geldanamycin-binding domain of Hsp90 (residues 9-232) reveals a pronounced pocket, 15 A deep, that is highly conserved across species. Geldanamycin binds inside this pocket, adopting a compact structure similar to that of a polypeptide chain in a turn conformation. This, and the pocket's similarity to substrate-binding sites, suggest that the pocket binds a portion of the polypeptide substrate and participates in the conformational maturation/refolding reaction.
Cited by 1,364 works. doi:10.1016/s0092-8674(00)80203-2 Open-access PDF
Authors
- C. Erec Stebbins
- Alicia A. Russo
- Christine B. Schneider
- Neal X. Rosen
- F. Ulrich Hartl
- Nikola P. Pavletich
References
- MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
- The CCP4 suite: programs for protein crystallography
- Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
- Raster3D Version 2.0. A program for photorealistic molecular graphics
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
- Protein Folding
- The Biology of heat shock proteins and molecular chaperones.
- Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation.
- Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.
- The value of estrogen and progesterone receptors in the treatment of breast cancer